Andrew Ashe

Insider Reports History

Entity
Individual
Location
C/O Dyax Corp., 55 Network Drive, Burlington, MA
Signature
/s/ Andrew Ashe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Ashe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. President, Chief Operating Officer Common Stock 343K $2.14M $6.26 May 14, 2024 Direct
Verve Therapeutics, Inc. President, Chief Operating Officer Restricted Stock Units 36K $360K $10.00 Feb 14, 2024 Direct
Verve Therapeutics, Inc. President, Chief Operating Officer Stock Option (right to buy) 150K Feb 14, 2024 Direct

Insider Reports Filed by Andrew Ashe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. May 14, 2024 1 $476K 4 May 15, 2024 President, Chief Operating Officer
VERV Verve Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 President, Chief Operating Officer and General Counsel
VERV Verve Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 President, Chief Operating Officer and General Counsel
VERV Verve Therapeutics, Inc. Aug 25, 2022 6 $152K 4 Aug 29, 2022 President, Chief Operating Officer and General Counsel
VERV Verve Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 President, Chief Operating Officer
VERV Verve Therapeutics, Inc. Dec 2, 2021 1 $128K 4 Dec 6, 2021 President, Chief Operating Officer
VERV Verve Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 President, Chief Operating Officer
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 President, Chief Operating Officer Exhibit Index: 24.1 Power of Attorney